Latest issue of Clinical laboratory
January 2026
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
SHIMADZU | CLAM-2040 goes live with RECIPE TDM platform
, /in Advertenties /by panglobalShimadzu has been paving the way for automated LC-MS/MS (CLAM series) since 2015. Now it’s time for the next step into the future of the clinical laboratory. Discover the IVD kits from the RECIPE ClinMass® TDM platform now available to be used on Shimadzu’s automated IVDR class A solutions for LC-MS/MS! Benefit from LCMS 24/7 […]
DIASYS | ResponsA1C
, /in Advertenties /by panglobalOne step HbA1c analyzer
WERFEN | HIT Testing in Minutes.
, /in Advertenties /by panglobalThe on-demand solution that saves more than time.
Lonza extends TheraPEAK portfolio with AmpliCell cytokines and 293-GT medium for cell and gene therapy manufacturing
, /in Product News /by panglobalLonza has launched two new products to strengthen its offering for cell and gene therapy developers: TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium. The additions address critical manufacturing requirements for immune cell expansion and adeno-associated virus (AAV) production, respectively.
Molcure partners with Boehringer Ingelheim to accelerate AI-driven antibody drug discovery
, /in E-News /by panglobalMOLCURE Inc. has announced a multiyear strategic research agreement with Boehringer Ingelheim to discover innovative antibody therapeutics for multiple targets using the Japanese company’s proprietary artificial intelligence platform technology. The collaboration will combine MOLCURE’s AI-driven platform with Boehringer Ingelheim’s expertise in biologics development, aiming to expand the scope and efficiency of antibody drug discovery beyond […]
Bio-Rad launches enhanced Liquichek Opiate Control
, /in Product News /by panglobalBio-Rad Laboratories, a global provider of life science research and clinical diagnostics products, has improved its Liquichek quality control product portfolio with the launch of an enhanced version of its Liquichek Opiate Control.
StemInov secures €10.6 million to advance mesenchymal stem cell therapy for severe pneumonia
, /in E-News /by panglobalFrench biopharmaceutical company StemInov has closed a €10.6 million financing round to support the industrialisation of its stem cell platform and prepare for Phase I/IIa clinical trials targeting severe pneumonia complications. The Nancy and Illkirch-Graffenstaden-based company, which specialises in mesenchymal stem cell (MSC) therapies for inflammatory and autoimmune diseases, expects to initiate patient recruitment in […]
Anti-laminin β4 – a new autoantibody marker in pemphigoid disease
, /in Autoimmunity & Allergy, Featured Articles /by panglobalLaminin β4 (lamβ4) has been identified as a novel target antigen in anti-p200 pemphigoid, a rare autoimmune disease manifesting with subepidermal blisters. Anti-lamβ4 antibodies bind to the region of the dermal–epidermal junction and demonstrate pathogenic effects. A recombinant-cell indirect immunofluorescence assay has been developed for specific detection of anti-lamβ4 antibodies.
Identification of putative breath biomarkers for detection of lymphoma
, /in Featured Articles, Hematology & Flow Cytometry /by panglobalVolatile organic compounds (VOCs) are released from our bodies in our breath, sweat, blood and urine as a result of metabolic activity and so provide a window on our metabolic and physiological status. These VOCs change in response to disease, providing the potential for disease-specific VOCs in the breath to be used as non-invasive biomarkers […]
ACD/Labs expands Katalyst D2D software capabilities for pharmaceutical development
, /in Product News /by panglobalACD/Labs has released version 25.4 of Katalyst D2D, extending the industry-leading workflow digitalisation software beyond its original high throughput experimentation applications to support process scale-up and material characterisation in pharmaceutical development. The enhanced platform enables pharmaceutical project teams to accelerate the design-make-test-analyse cycle from discovery through to clinical trials.